These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36623638)

  • 1. Bevacizumab for retinopathy of prematurity and neurodevelopment.
    Binenbaum G
    J AAPOS; 2023 Feb; 27(1):1-2. PubMed ID: 36623638
    [No Abstract]   [Full Text] [Related]  

  • 2. Bevacizumab for retinopathy of prematurity and neurodevelopment.
    Wallace DK;
    J AAPOS; 2024 Feb; 28(1):103786. PubMed ID: 37926389
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravitreal bevacizumab injection for retinopathy of prematurity and pulmonary hypertension.
    Park L; Donohue L; Lakshminrusimha S; Sankaran D
    J Perinatol; 2023 Feb; 43(2):236-237. PubMed ID: 35970854
    [No Abstract]   [Full Text] [Related]  

  • 4. [Neurodevelopment in patients with retinopathy of prematurity treated with intravitreal bevacizumab. Case series].
    Martínez-García SM; Hernández-Da Mota SE; Rubio-Rangel A; Rojas-Flores I; Vieyra-López ME; Martínez-Castellanos MA; Zavala-Martínez MT; Gómez García A
    Cir Cir; 2017; 85(6):478-484. PubMed ID: 28110900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: Freedman et al: Low- and very low-dose bevacizumab for retinopathy of prematurity: reactivations, additional treatments, and 12-month outcomes (Ophthalmology. 2022;129:1120-1128).
    Asensio-Sánchez VM
    Ophthalmology; 2023 May; 130(5):e18. PubMed ID: 36702728
    [No Abstract]   [Full Text] [Related]  

  • 6. Fundus Pigmentation in the Diagnosis and Treatment of Retinopathy of Prematurity.
    Fan KC; Read SP; Patel NA; Vanner EA; Al-Khersan H; Laura DM; Pakravan P; Negron CI; Berrocal AM
    Ophthalmology; 2021 Aug; 128(8):1242-1244. PubMed ID: 33383092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal Bevacizumab for Retinopathy of Prematurity: Another Hit to the Immature Lung?
    Oulego-Erroz I; Alonso-Ojembarrena A
    Chest; 2022 Dec; 162(6):1231-1232. PubMed ID: 36494122
    [No Abstract]   [Full Text] [Related]  

  • 8. Retinopathy of Prematurity: Intravitreal injections of bevacizumab: timing, technique, and outcomes.
    Mintz-Hittner HA
    J AAPOS; 2016 Dec; 20(6):478-480. PubMed ID: 27816750
    [No Abstract]   [Full Text] [Related]  

  • 9. OUTCOMES OF NONCONFLUENT DIODE LASER PANRETINAL PHOTOCOAGULATION FOR AGGRESSIVE POSTERIOR RETINOPATHY OF PREMATURITY AFTER INTRAVITREAL BEVACIZUMAB.
    Mammo DA; Rubino SM; Quiram PA
    Retina; 2021 Apr; 41(4):706-710. PubMed ID: 32796444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal bevacizumab for retinopathy of prematurity: Considerations for informed consent.
    Mireskandari K; Collins ME; Tehrani N
    Can J Ophthalmol; 2015 Dec; 50(6):409-12. PubMed ID: 26651298
    [No Abstract]   [Full Text] [Related]  

  • 11. Very Late Reactivation of Retinopathy of Prematurity After Monotherapy With Intravitreal Bevacizumab.
    Snyder LL; Garcia-Gonzalez JM; Shapiro MJ; Blair MP
    Ophthalmic Surg Lasers Imaging Retina; 2016 Mar; 47(3):280-3. PubMed ID: 26985803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of intravitreal bevacizumab for zone-II retinopathy of prematurity.
    Karkhaneh R; Khodabande A; Riazi-Eafahani M; Roohipoor R; Ghassemi F; Imani M; Dastjani Farahani A; Ebrahimi Adib N; Torabi H
    Acta Ophthalmol; 2016 Sep; 94(6):e417-20. PubMed ID: 27009449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Slow progressive perifoveal vascular formation in an infant with aggressive posterior retinopathy of prematurity.
    Chen X; Imperio R; Seely KR; Viehland C; Izatt JA; Prakalapakorn SG; Freedman SF; Toth CA
    J AAPOS; 2020 Oct; 24(5):323-326. PubMed ID: 33045380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A lower dose of intravitreal bevacizumab effectively treats retinopathy of prematurity.
    Khodabande A; Niyousha MR; Roohipoor R
    J AAPOS; 2016 Dec; 20(6):490-492. PubMed ID: 27794470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refractive outcome of intravitreal bevacizumab injection in comparison to spontaneous regression of retinopathy of prematurity (ROP).
    Etezad Razavi M; Shoeibi N; Hassanzadeh S; Kianmehr S; Bakhtiari E
    Strabismus; 2020 Mar; 28(1):49-54. PubMed ID: 31790628
    [No Abstract]   [Full Text] [Related]  

  • 16. Choice of Dose Level for a Randomized Clinical Trial of Low-Dose Bevacizumab vs Laser for Type 1 Retinopathy of Prematurity.
    Kraker RT; Wallace DK; Beck RW; Saunders CT; Lorenzi E; Melia BM; Li Z;
    JAMA Ophthalmol; 2021 Oct; 139(10):1143-1144. PubMed ID: 34410311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypotension Associated With Intravitreal Bevacizumab Therapy for Retinopathy of Prematurity.
    Wu LH; Yang YH; Lin CH; Lin YJ; Cheng CL
    Pediatrics; 2016 Feb; 137(2):e20152005. PubMed ID: 26743817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bevacizumab for retinopathy of prematurity.
    Gilbert CE; Zin A; Darlow B
    N Engl J Med; 2011 Jun; 364(24):2359-60; author reply 2361-2. PubMed ID: 21675898
    [No Abstract]   [Full Text] [Related]  

  • 19. Timing of laser following intravitreal anti-vascular endothelial growth factor injections for aggressive posterior zone 1 retinopathy of prematurity.
    Vinekar A
    Indian J Ophthalmol; 2021 Aug; 69(8):1988-1989. PubMed ID: 34304161
    [No Abstract]   [Full Text] [Related]  

  • 20. A rare association of intravitreal bevacizumab injection with double ridge formation in retinopathy of prematurity.
    Yaz Y; Erol N; Gursoy H; Basmak H; Bilgec MD
    J Pediatr Ophthalmol Strabismus; 2014 Oct; 51 Online():e66-8. PubMed ID: 25333243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.